Galimedix, Inc. | WebDisclosure

Basculer en Français

11119	Companies
244820	Keywords
172890	Articles
132003	Press releases

Home
Companies
Galimedix, Inc.

PRESS RELEASE

published on 03/08/2024 at 10:00, 2 years 6 months ago

Galimedix Therapeutics presents new scientific data showing promising neuroprotective effects of GAL-201 for the treatment of Alzheimer’s disease at AD/PD™ 2024
Galimedix Therapeutics presents new scientific data at AD/PD(TM) 2024, showing neuroprotective effects of GAL-201 for Alzheimer’s disease treatment, targeting misfolded Aβ monomers to prevent toxic aggregation

Alzheimer's Disease Galimedix Therapeutics Neuroprotective Effects Scientific Data AD/PD 2024
PRESS RELEASE

published on 02/28/2024 at 14:00, 2 years 7 months ago

Galimedix Therapeutics announces new pre-clinical data with GAL-201 in an Alzheimer's disease transgenic model to be presented at AD/PD™ 2024 Conference
Galimedix Therapeutics to present new pre-clinical data with GAL-201 in an Alzheimer's disease transgenic model at AD/PD™ 2024 Conference, showing promise in targeting amyloid beta oligomers and protofibrils

Alzheimer's Disease GAL-201 Galimedix Therapeutics Pre-clinical Data AD/PD™ 2024 Conference
BRIEF

published on 02/28/2024 at 14:00, 2 years 7 months ago

Galimedix Therapeutics Presents New Preclinical Data on GAL-201 at AD/PD™ 2024 Conference

Alzheimer's Disease GAL-201 AD/PD™ 2024 Galimedix Therapeutics Preclinical
BRIEF

published on 02/28/2024 at 14:00, 2 years 7 months ago

Galimedix Therapeutics présente de nouvelles données précliniques sur le GAL-201 lors de la conférence AD/PD™ 2024

GAL-201 Maladie D'Alzheimer Préclinique AD/PD™ 2024 Galimedix Therapeutics
PRESS RELEASE

published on 10/25/2023 at 14:00, 2 years 11 months ago

Galimedix Appoints Dr. Luciana Summo as Vice President, R&D Operations

Accesswire

Published on 10/03/2026 at 02:35, 2 days 3 hours ago

Jaguar Health Announces a Special Stock Dividend
Published on 10/02/2026 at 17:45, 2 days 12 hours ago

Sparton Provides Status Update
Published on 10/02/2026 at 13:50, 2 days 16 hours ago

AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
Published on 10/02/2026 at 13:00, 2 days 17 hours ago

Evergold Drills 4.9 m of 7.70 g/t Au and 186.0 g/t Ag Within 13.5 Metres of 2.84 g/t Au and 127.6 g/t Ag in First 2026 Drill Holes at Golden Lion
Published on 10/02/2026 at 13:00, 2 days 17 hours ago

Alaska Energy Metals Appoints Independent Director, Thomas Benson

View all ACCESSWIRE

EQS Group

Published on 10/05/2026 at 00:05, 6 hours 3 minutes ago

TerraMaster lance sa saison de mise à niveau du stockage avec jusqu’à 30 % de réduction à l’occasion des Prime Big Deal Days
Published on 10/04/2026 at 06:05, 1 day ago

Blokees Debuts 90+ New Products at Wonder Festival Shanghai 2026
Published on 10/04/2026 at 05:15, 1 day ago

SIBIONICS and PharmaSens Explore New Horizons for Automated Insulin Delivery at EASD 2026
Published on 10/03/2026 at 15:45, 1 day 14 hours ago

Huawei Highlights Continuous Innovation, Securing Competitive Edge Through Technological Breakthroughs
Published on 10/02/2026 at 23:55, 2 days 6 hours ago

IS SKINCARE GETTING TOO COMPLICATED? CERAVE MAKES THE CASE FOR SAFETY, EFFICACY AND SIMPLICITY

Les Echos

Published on 10/02/2026 at 17:45, 2 days 12 hours ago

Information concerning the total number of voting rights and shares 2026 09 30
Published on 10/02/2026 at 17:45, 2 days 12 hours ago

Informations relatives au nombre total de droits de vote et d’actions 2026 09 30
Published on 10/02/2026 at 17:35, 2 days 12 hours ago

Peugeot Invest - Déclaration du nombre d'actions et de droits de vote
Published on 10/02/2026 at 17:30, 2 days 12 hours ago

Aéroports de Paris SA - 2027 Financial Calendar
Published on 10/02/2026 at 17:30, 2 days 12 hours ago

Aéroports de Paris SA - Calendrier financier 2027

View all LES ECHOS COMFI WIRE